Laurus Labs Limited (NSE: LAURUSLABS)
India
· Delayed Price · Currency is INR
585.15
+14.30 (2.51%)
Jan 23, 2025, 3:30 PM IST
Laurus Labs Revenue
Laurus Labs had revenue of 12.24B INR in the quarter ending September 30, 2024, a decrease of -0.06%. This brings the company's revenue in the last twelve months to 50.53B, down -5.23% year-over-year. In the fiscal year ending March 31, 2024, Laurus Labs had annual revenue of 50.41B, down -16.55%.
Revenue (ttm)
50.53B
Revenue Growth
-5.23%
P/S Ratio
6.25
Revenue / Employee
8.41M
Employees
6,007
Market Cap
315.54B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 50.41B | -10.00B | -16.55% |
Mar 31, 2023 | 60.41B | 11.05B | 22.39% |
Mar 31, 2022 | 49.36B | 1.22B | 2.54% |
Mar 31, 2021 | 48.14B | 19.82B | 69.99% |
Mar 31, 2020 | 28.32B | 5.40B | 23.55% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 503.08B |
Divi's Laboratories | 86.14B |
Cipla | 262.64B |
Mankind Pharma | 110.18B |
Zydus Lifesciences | 214.84B |
Apollo Hospitals Enterprise | 204.69B |
Aurobindo Pharma | 302.95B |
Alkem Laboratories | 128.32B |
Laurus Labs News
- 22 days ago - Stock Market Update, January 1: Muthoot Finance, Jubilant FoodWorks, Laurus Labs, Praj Industries and more hit 52-week highs today - Business Upturn
- 23 days ago - Stock Market Update, December 31: Laurus Labs, Lupin, CRISIL and more hit 52-week highs today - Business Upturn
- 6 weeks ago - Mixed trends in November CDRMO exports, prefer Syngene and Neuland Labs over Divis Labs and Laurus Labs - Business Upturn
- 6 weeks ago - Laurus Bio secures 120 cr investment - The Times of India
- 2 months ago - T’gana pharma biggies to inject 5,200cr in Pharma City, create over 12,000 jobs - The Times of India
- 2 months ago - Pharma Sector Stocks: Granules down 1.68%, Akums slips 1.29%, Zydus Life up 0.13%, Aurobindo Pharma gains 0.99% in early trade - Business Upturn
- 3 months ago - Laurus Labs Ltd (BOM:540222) Q2 2025 Earnings Call Highlights: Navigating Challenges with ... - GuruFocus
- 3 months ago - Laurus Labs Q2 FY25 Results: Revenue flat, net profit declines 55% YoY - Business Upturn